Direct-Acting Antiviral Therapy and Risk of Hepatocellular Carcinoma Recurrence in Patients with Chronic Hepatitis C

Lignende værker

• Independent Risk Factors for Hepatocellular Carcinoma Recurrence after Direct-Acting Antiviral Therapy in Patients with Chronic Hepatitis C
  af: Ahn, Young-Hwan, et al.
  Udgivet: (2021)
• Impact of treating chronic hepatitis C infection with direct-acting antivirals on the risk of hepatocellular carcinoma recurrence
  af: Nevine Ibrahim Musa, et al.
  Udgivet: (2020-07-01)
• Impact of direct-acting antiviral therapy for hepatitis C–related hepatocellular carcinoma
  af: Lin, Wei-Chen, et al.
  Udgivet: (2020)
• The impact of direct-acting antiviral therapy for hepatitis C on hepatocellular carcinoma risk.
  af: Su, Feng, et al.
  Udgivet: (2018)
• Direct-acting antivirals for patients with chronic hepatitis C and hepatocellular carcinoma in Taiwan
  af: Chen-Ta Chi, et al.
  Udgivet: (2021-06-01)